The correlations between GPX3 expression and the clinical characteristics of several human cancers, including COAD, prostate adenocarcinoma (PRAD), KIRC, LUAD, and STAD, are shown in Table 1. This evidence concerns the gene GPX3 and colon adenocarcinoma.